Kyoto, Japan

Shinichi Okamoto

This inventor holds 1 USPTO granted patent. Top assignee: Nitto-Denko Corporation. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shinichi Okamoto. Retrieved from https://idiyas.com/inventor/shinichi-okamoto-aji2mscs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shinichi Okamoto: Innovator in Hard Tissue Regeneration

Introduction

Shinichi Okamoto is a prominent inventor based in Kyoto, Japan. He has made significant contributions to the field of biomedical engineering, particularly in the area of hard tissue regeneration. His innovative work has the potential to greatly impact medical treatments and improve patient outcomes.

Latest Patents

Shinichi Okamoto holds a patent for a material designed for the induction of hard tissue regeneration. This invention, which comprises platelet-rich plasma and gelatin β-TCP sponge, promotes angiogenesis, osteogenesis, and chondrogenesis. His patent is a testament to his commitment to advancing medical technology and improving regenerative medicine.

Career Highlights

Okamoto is associated with Nitto Denko Corporation, where he applies his expertise in developing materials that enhance healing processes. His work at the company has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

One of his notable collaborators is Yasuhiko Tabata. Together, they have worked on projects that focus on innovative solutions for tissue engineering and regenerative medicine.

Conclusion

Shinichi Okamoto's contributions to hard tissue regeneration exemplify the importance of innovation in the medical field. His work not only advances scientific knowledge but also holds promise for future medical applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…